News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 361โ396
- Matches
- 21528
- Sources here
- 19
- Companies here
- 32
Active search
21528 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Non-controlling/minority interest of BlackRock Capital Allocation Term Trust โ TRADEGATE:BD8
This article provides financial information specifically on the non-controlling/minority interest of BlackRock Capital Allocation Term Trust (BD8) traded on Tradegate Exchange. It details the period, value, and change metrics for this financial aspect. The content is presented within a financial data platform interface.
CPRI (Capri Holdings) Technical Outlook for NYSE:CPRI by keskinm
Capri Holdings (CPRI) stock is in the final phase of a downtrend that began in December 2025, having broken a 16-month rising support line and reaching a new 52-week low. The breakdown lacked heavy volume, and despite an oversold RSI, a reversal signal is โฆ
AAOI Stock Dips 10% Overnight After $600M Equity Offering Triggers Dilution Concerns
Applied Optoelectronics (AAOI) stock dropped over 10% overnight after the company announced a $600 million at-the-market equity offering, sparking dilution concerns among investors. While some traders expressed anger, others argued the capital raise is crucial for capacity expansion to meet soaring demand in the โฆ
Jim Cramer Defends Apple Inc. (NASDAQ: AAPL) Amid Memory Shortage Pressure And Mixed Earnings Results
Jim Cramer has defended Apple Inc. (NASDAQ: AAPL) despite facing pressure from a global memory chip shortage and mixed earnings results. Cramer highlighted Apple's efforts in American manufacturing and the challenges in memory procurement due to high demand from other tech giants. While iPhone โฆ
Intellia Therapeutics Inc Stock Historical Valuations | XTER:38I
This page provides a stock summary for Intellia Therapeutics Inc (XTER:38I), including its current stock price (โฌ11.1), market capitalization (โฌ1.54B), P/B ratio (2.47), and enterprise value (โฌ1.23B) as of August 21. It also notes that GuruFocus has detected three severe warning signs for the โฆ
The Bull Case For Axsome Therapeutics (AXSM) Could Change Following Rising Revenue And Widening Net Losses
Axsome Therapeutics (AXSM) reported increased revenue for Q2 and H1 2026, but also experienced widening net losses due to expansion costs. The company's investment narrative hinges on its CNS portfolio, particularly Auvelity and Sunosi, eventually offsetting these losses, with the FDA's acceptance of AXS-12 โฆ
Certain Warrants of ProQR Therapeutics N.V. are subject to a Lock-Up Agreement Ending on 24-AUG-2026.
Certain warrants of ProQR Therapeutics N.V. are currently under a lock-up agreement, which began on June 25, 2026, and is set to expire on August 24, 2026. During this period, officers and directors are restricted from directly or indirectly selling, pledging, or otherwise disposing โฆ